Pharmacokinetics of ramipril in hypertensive patients with renal insufficiency
β Scribed by H. Schunkert; J. Kindler; M. Gassmann; W. Lahn; R. Irmisch; E. Ritz; E. R. Debusmann; J. O. Pujadas; K. M. Koch; H. -G. Sieberth
- Publisher
- Springer
- Year
- 1989
- Tongue
- English
- Weight
- 958 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Intravenous pulse administration of cyclophosphamide (cyc) has been successfully used for the treatment of various autoimmune diseases. these patients often present with impaired renal function or even end-stage renal failure. nevertheless, data concerning pharmacokinetics of cyc in
The pharmacokinetics of IV meropenem (500 mg over 30 min) has been studied in 6 healthy volunteers and 26 patients with various degrees of renal impairment. Blood samples were taken at different times over 24 h in healthy subjects and 36 to 48 h in uraemic patients, and four or five urine samples we